Prophylactic administration of a clinically safe low dose of the COVID-19 drug candidate Rejuveinix (RJX) effectively prevents fatal cytokine storm and mitigates inflammatory organ injury in a mouse model of sepsis
暂无分享,去创建一个
F. Uckun | K. Şahin | I. Ozercan | N. Şahin | C. Orhan | Natalie M. Pizzimenti | Joy Powell | A. VolkMichael